EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Biomimetic Nanomaterials Based on Peptide In Situ Self‐Assembly for Immunotherapy Applications

Zhuan Wen iD, Zhang-Zhi Song iD, Ming-Ze Cai iD, Ni-Yuan Zhang iD, Hao-Ze Li iD, Yang Yang iD, Qian-Ting Wang iD, Muhammad Hamza Ghafoor iD, Hong-Wei An iD, Hao Wang iD

WIREs Nanomedicine and Nanobiotechnology · 2025-01 · 17 (1)

DOI: 10.1002/wnan.70005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift WIREs Nanomedicine and Nanobiotechnology, online erschienen am 02.02.2025. Verfasst von Zhuan Wen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Henan Institute of Advanced Technology, Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Immunotherapy, Biomimetic Materials, Nanostructures, Peptides. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 121 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Beijing Nova Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer remains the leading cause of patient death worldwide and its incidence continues to rise. Immunotherapy is rapidly developing due to its significant differences in the mechanism of action from conventional radiotherapy and targeted antitumor drugs. In the past decades, many biomaterials have been designed and prepared to construct therapeutic platforms that modulate the immune system against cancer. Immunotherapeutic platforms utilizing biomaterials can markedly enhance therapeutic efficacy by optimizing the delivery of therapeutic agents, minimizing drug loss during circulation, and amplifying immunomodulatory effects. The intricate physiological barriers of tumors, coupled with adverse immune environments such as inadequate infiltration, off‐target effects, and immunosuppression, have emerged as significant obstacles impeding the effectiveness of oncology drug therapy. However, most of the current studies are devoted to the development of complex immunomodulators that exert immunomodulatory functions by loading drugs or adjuvants, ignoring the complex physiological barriers and adverse immune environments of tumors. Compared with conventional biomaterials, biomimetic nanomaterials based on peptide in situ self‐assembly with excellent functional characteristics of biocompatibility, biodegradability, and bioactivity have emerged as a novel and effective tool for cancer immunotherapy. This article presents a comprehensive review of the latest research findings on biomimetic nanomaterials based on peptide in situ self‐assembly in tumor immunotherapy. Initially, we categorize the structural types of biomimetic peptide nanomaterials and elucidate their intrinsic driving forces. Subsequently, we delve into the in situ self‐assembly strategies of these peptide biomimetic nanomaterials, highlighting their advantages in immunotherapy. Furthermore, we detail the applications of these biomimetic nanomaterials in antigen presentation and modulation of the immune microenvironment. In conclusion, we encapsulate the challenges and prospective developments of biomimetic nanomaterials based on peptide in situ self‐assembly for clinical translation in immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyBiomimetic MaterialsNanostructuresPeptidesNeoplasmsHumansAnimals

Stichwörter der Autor:innen

biomimetic nanomaterialscancer immunotherapypeptide self‐assemblytumor microenvironment

Substanzen

Peptides

Autor:innen und Institutionen

  • Henan Institute of Advanced Technology, Zhengzhou University, Zhengzhou, China.
  • CAS Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology (NCNST), Beijing, China.
  • Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing, China.

ORCID-Profile: Zhuan Wen, Zhang-Zhi Song, Ming-Ze Cai, Ni-Yuan Zhang, Hao-Ze Li, Yang Yang, Qian-Ting Wang, Muhammad Hamza Ghafoor, Hong-Wei An, Hao Wang

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Beijing Nova Program

Zitieren

APA

Wen, Z., Song, Z. Z., Cai, M. Z., Zhang, N. Y., Li, H. Z., Yang, Y., Wang, Q. T., Ghafoor, M. H., An, H. W., & Wang, H. (2025). Biomimetic Nanomaterials Based on Peptide In Situ Self‐Assembly for Immunotherapy Applications. WIREs Nanomedicine and Nanobiotechnology, 17(1). https://doi.org/10.1002/wnan.70005

Vancouver

Wen Z, Song ZZ, Cai MZ, Zhang NY, Li HZ, Yang Y, et al. Biomimetic Nanomaterials Based on Peptide In Situ Self‐Assembly for Immunotherapy Applications. WIREs Nanomedicine and Nanobiotechnology. 2025;17(1). doi:10.1002/wnan.70005

BibTeX
@article{Wen2025,
  author = {Wen, Zhuan and Song, Zhang-Zhi and Cai, Ming-Ze and Zhang, Ni-Yuan and Li, Hao-Ze and Yang, Yang and Wang, Qian-Ting and Ghafoor, Muhammad Hamza and An, Hong-Wei and Wang, Hao},
  title = {Biomimetic Nanomaterials Based on Peptide In Situ Self‐Assembly for Immunotherapy Applications},
  journal = {WIREs Nanomedicine and Nanobiotechnology},
  year = {2025},
  volume = {17},
  number = {1},
  doi = {10.1002/wnan.70005}
}
Kostenlos starten →